rs751269562
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000543.5(SMPD1):c.314T>C(p.Leu105Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L105L) has been classified as Likely benign.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Publications
- acid sphingomyelinase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Niemann-Pick diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Niemann-Pick disease type AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- Niemann-Pick disease type BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 249832 AF XY: 0.00000739 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461836Hom.: 0 Cov.: 38 AF XY: 0.00000413 AC XY: 3AN XY: 727214 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:3
ClinVar contains an entry for this variant (Variation ID: 556092). This variant is also known as c.308T>C (p.L103P). This missense change has been observed in individual(s) with Niemann-Pick disease (PMID: 15221801, 22818240, 33083013, 34273913). This variant is present in population databases (rs751269562, gnomAD 0.0009%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 105 of the SMPD1 protein (p.Leu105Pro). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 16010684, 34273913). -
- -
- -
Niemann-Pick disease, type A Pathogenic:2
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Niemann-Pick disease, type B Pathogenic:1
A homozygous missense variant in exon 1 of the SMPD1 gene that results in the amino acid substitution of Proline for Leucine at codon 105 was detected. The observed variant c.314T>C (p.Leu105Pro) has not been reported in the 1000 genomes databases and has a MAF of 0.0004% in the gnomAD database. This variant has previously been reported in patients affected with MPS I (PMID: 31941852). The in-silico prediction of the variant is deleterious by MutationTaster, FATHMM and DANN. In summary, the variant meets our criteria to be classified as pathogenic. -
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Variant summary: SMPD1 c.314T>C (p.Leu105Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249832 control chromosomes. c.314T>C has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Niemann-Pick Disease (e.g., Hollack_2012, Ranganath_2016, Cheema_2020, Deshpande_2021). These data indicate that the variant is very likely to be associated with disease. Multiple publications report experimental evidence evaluating an impact on protein function; the most pronounced variant effect results in approximately 2-3% of normal activity (Dardis_2005, Deshpande_2021). The following publications have been ascertained in the context of this evaluation (PMID: 33083013, 16010684, 34273913, 22818240, 27338287). ClinVar contains an entry for this variant (Variation ID: 556092). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at